TITLE

The role of thromboxane in cuprophan-induced pulmonary hypertension

AUTHOR(S)
Cheung, Alfred K.; Baranowski, Robert L.; Wayman, Andrea L.
PUB. DATE
May 1987
SOURCE
Kidney International;May1987, Vol. 31 Issue 5, p1072
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Previous studies demonstrated that acute infusion of cuprophan activated plasma into experimental animals produce cardiopulmonary changes which included severe pulmonary hypertension. It was further suggested that these changes were mediated by complement activation products. The current study examined the role of arachidonic acid metabolites in the pathogenesis of cuprophan-induced pulmonary hypertension in the swine. Plasma thromboxane concentrations and pulmonary arterial pressure rose concomitantly with cuprophan-activated plasma infusion; both could be inhibited by the specific thromboxane synthetase inhibitor, OKY1581. Likewise, this inhibitor also blocked the increment in plasma thromboxane concentrations and pulmonary arterial pressure induced by zymosan-activated plasma. In vitro incubation of cuprophan-activated plasma with porcine lung fragments produced significantly higher thromboxane concentrations in the medium than incubation with other porcine tissues examined. It is postulated that the complement activation products formed in the plasma during cuprophan exposure subsequently stimulated release of thromboxane from the lungs and other tissues upon infusion of the plasma into animals. The thromboxane, in turn, triggers the pulmonary hypertension.
ACCESSION #
17676154

 

Related Articles

  • Intercalated cells of the rat inner medullary collecting duct. Clapp, William L.; Madsen, Kirsten M.; Verlander, Jill W.; Tisher, C. Craig // Kidney International;May1987, Vol. 31 Issue 5, p1080 

    Previous studies demonstrated that acute infusion of cuprophan activated plasma into experimental animals produce cardiopulmonary changes which included severe pulmonary hypertension. It was further suggested that these changes were mediated by complement activation products. The current study...

  • Single Intraperitoneal Injection of Monocrotaline as a Novel Large Animal Model of Chronic Pulmonary Hypertension in Tibet Minipigs. Zeng, Guang-qiao; Liu, Rong; Liao, Hai-xing; Zhang, Xin-feng; Qian, Yuan-xin; Liu, Bao-hua; Wu, Qing-hong; Zhao, Jin; Gu, Wei-wang; Li, Hong-tao // PLoS ONE;Nov2013, Vol. 8 Issue 11, p1 

    Objective: The purpose of this study was to establish an animal model of chronic pulmonary hypertension with a single-dose intraperitoneal injection of monocrotaline (MCT) in young Tibet minipigs, so as to enable both invasive and noninvasive measurements and hence facilitate future studies....

  • Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets. Hirenallur-S, Dinesh K.; Detweiler, Neil D.; Haworth, Steven T.; Leming, Jeaninne T.; Gordon, John B.; Rusch, Nancy J. // Pulmonary Circulation;2012, Vol. 2 Issue 2, p193 

    The development of pulmonary arterial hypertension (PAH) in pediatric patients has been linked to the production of the arachidonic acid metabolite, thromboxane A2 (TxA2). The present study evaluated the therapeutic effect of furegrelate sodium, a thromboxane synthase inhibitor, on the...

  • Dose-response effects of milrinone on hemodynamics of newborn pigs with hypoxia-reoxygenation. Joynt, Chloë; Bigam, David L.; Charrois, Gregory; Jewell, Laurence D.; Korbutt, Gregory; Po-Yin Cheung // Intensive Care Medicine;Jul2008, Vol. 34 Issue 7, p1321 

    Neonatal asphyxia causes cardiogenic shock and pulmonary hypertension with decreased brain perfusion. We examined the dose-response of milrinone on systemic, pulmonary, and carotid circulations in a model of neonatal hypoxia-reoxygenation. Controlled, block-randomized study in a university...

  • Effects of Exogenous Sphinganine, Sphingosine, and Sphingosine-1-Phosphate on Relaxation and Contraction of Porcine Thoracic Aortic and Pulmonary Arterial Rings. Shih-Hsuan Hsiao; Constable, Peter D.; Smith, Geoffrey W.; Haschek, Wanda M. // Toxicological Sciences;Jul2005, Vol. 86 Issue 1, p194 

    Fumonisin mycotoxicosis in pigs causes a decrease in mean aortic pressure, an increase in mean pulmonary arterial pressure, and increases in serum concentrations of sphinganine (3.2 μM) and sphingosine (1.4 μM). To determine a causal relationship between the hemodynamic changes and...

  • Combination Proximal Pulmonary Artery Coiling and Distal Embolization Induces Chronic Elevations in Pulmonary Artery Pressure in Swine. Aguero, Jaume; Ishikawa, Kiyotake; Fish, Kenneth M.; Hammoudi, Nadjib; Hadri, Lahouaria; Garcia-Alvarez, Ana; Ibanez, Borja; Fuster, Valentin; Hajjar, Roger J.; Leopold, Jane A. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Pulmonary hypertension (PH) is associated with aberrant vascular remodeling and right ventricular (RV) dysfunction that contribute to early mortality. Large animal models that recapitulate human PH are essential for mechanistic studies and evaluating novel therapies; however, these models are...

  • Emission-Particle-Induced Ventilatory Abnormalities in a Rat Model of Pulmonary Hypertension. Gardner, Sarah Y.; McGee, John K.; Kodavanti, Urmila P.; Ledbetter, Allen; Everitt, Jeffrey I.; Winsett, Darrell W.; Doerfler, Donald L.; Costa, Daniel L. // Environmental Health Perspectives;Jun2004, Vol. 112 Issue 8, p872 

    Preexistent cardiopulmonary disease in humans appears to enhance susceptibility to the adverse effects of ambient particulate matter. Previous studies in this laboratory have demonstrated enhanced inflammation and mortality after intratracheal instillation (IT) and inhalation (INH) of residual...

  • Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension. Gubrij, Igor B.; Pangle, Amanda K.; Pang, Li; Johnson, Larry G. // PLoS ONE;1/27/2016, Vol. 11 Issue 1, p1 

    Background: Animals models have played an important role in enhancing our understanding of the pathogenesis of pulmonary arterial hypertension (PAH). Dysregulation of the profile of microRNAs (miRNAs) has been demonstrated in human tissues from PAH patients and in animal models. In this study,...

  • Author's Reply. Das, Mita; Fessel, Joshua; West, James // Pulmonary Circulation;Apr-Jun2013, Vol. 3 Issue 2, p447 

    A response from the author of the article regarding the study of human disease by using a mouse model in pulmonary vascular stress is presented.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics